JENNE KYLE (Chief Commercial Officer) sold 1.4% of their position (720.00 shares) of AKCEA THERAPEUTICS, INC. on the open market
Open‑market sale worth $13.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/24/2020ACC: 0001209191-20-051891
Officer· Chief Commercial Officer
Since Oct 2019
-720.00
Net shares
Net seller
$13.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
720.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−720.00
Price / share
$18.12
Trade value
$13.05K
% of position
1.4%
9/22/2020
52.73K→52.01K
Total
Net shares
−720.00
Net value
-$13.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/22/2020 | S · Sale | −720.00 | $18.12 | $13.05K | 1.4% | 52.73K | 52.01K |
| Total | −720.00 | -$13.05K | ||||||
Derivative Transactions0
No derivative transactions reported